Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge
CTGF is upregulated in patients with idiopathic pulmonary fibrosis (IPF), characterized by the deposition of a pathological extracellular matrix (ECM). Additionally, many omics studies confirmed that aberrant cellular senescence-associated mitochondria dysfunction and metabolic reprogramming had bee...
Main Authors: | Wiwin Is Effendi, Tatsuya Nagano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/11/6064 |
Similar Items
-
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
by: Wiwin Is Effendi, et al.
Published: (2021-12-01) -
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
by: Wiwin Is Effendi, et al.
Published: (2023-02-01) -
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
by: Hana Alsomali, et al.
Published: (2023-02-01) -
Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
by: Lorraine Thong, et al.
Published: (2023-02-01) -
The association of plasma connective tissue growth factor levels with left ventricular diastolic dysfunction in patients with overt hyperthyroidism
by: Huan Li, et al.
Published: (2024-02-01)